Human medicines European public assessment report (EPAR): Pegasys, peginterferon alfa-2a, Hepatitis C, Chronic,Hepatitis B, Chronic, Date of authorisation: 20/06/2002, Revision: 37, Status: Authorised

Case Medical Research ◽

10.31525/cmr-1e9ffb7 ◽

2019 ◽

Author(s):

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Peginterferon Alfa

Download Full-text

Human medicines European public assessment report (EPAR): IntronA, interferon alfa-2b, Carcinoid Tumor,Leukemia, Hairy Cell,Lymphoma, Follicular,Hepatitis B, Chronic,Hepatitis C, Chronic,Leukemia, Myelogenous, Chronic, BCR-ABL Positive,Melanoma,Multiple Myeloma, Date of authorisation: 09/03/2000, Revision: 31, Status: Authorised

Case Medical Research ◽

10.31525/cmr-39964f ◽

2019 ◽

Author(s):

Keyword(s):

Multiple Myeloma ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Hepatitis B ◽

Cell Lymphoma ◽

Interferon Alfa ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): IntronA, interferon alfa-2b, Carcinoid Tumor,Leukemia, Hairy Cell,Lymphoma, Follicular,Hepatitis B, Chronic,Hepatitis C, Chronic,Leukemia, Myelogenous, Chronic, BCR-ABL Positive,Melanoma,Multiple Myeloma, Date of authorisation: 09/03/2000, Revision: 31, Status: Authorised

Case Medical Research ◽

10.31525/cmr-fcd076 ◽

2019 ◽

Author(s):

Keyword(s):

Multiple Myeloma ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Hepatitis B ◽

Cell Lymphoma ◽

Interferon Alfa ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): ViraferonPeg, peginterferon alfa-2b, Hepatitis C, Chronic, Date of authorisation: 28/05/2000, Revision: 36, Status: Authorised

Case Medical Research ◽

10.31525/cmr-39972f ◽

2018 ◽

Author(s):

Keyword(s):

Hepatitis C ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Peginterferon Alfa

Download Full-text

Human medicines European public assessment report (EPAR): PegIntron, peginterferon alfa-2b, Hepatitis C, Chronic, Date of authorisation: 24/05/2000, Revision: 36, Status: Authorised

Case Medical Research ◽

10.31525/cmr-5ee334 ◽

2018 ◽

Author(s):

Keyword(s):

Hepatitis C ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Peginterferon Alfa

Download Full-text

Human medicines European public assessment report (EPAR): PegIntron, peginterferon alfa-2b, Hepatitis C, Chronic, Date of authorisation: 24/05/2000, Revision: 36, Status: Authorised

Case Medical Research ◽

10.31525/cmr-5ed96d ◽

2018 ◽

Author(s):

Keyword(s):

Hepatitis C ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Peginterferon Alfa

Download Full-text

Human medicines European public assessment report (EPAR): Ribavirin Mylan (previously Ribavirin Three Rivers), ribavirin, Hepatitis C, Chronic, Date of authorisation: 10/06/2010, Revision: 10, Status: Authorised

Case Medical Research ◽

10.31525/cmr-1907582 ◽

2019 ◽

Author(s):

Keyword(s):

Hepatitis C ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Download Full-text

Human medicines European public assessment report (EPAR): Baraclude, entecavir, Hepatitis B, Chronic, Date of authorisation: 26/06/2006, Revision: 24, Status: Authorised

Case Medical Research ◽

10.31525/cmr-134bca4 ◽

2019 ◽

Author(s):

Keyword(s):

Hepatitis B ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Entecavir Mylan, entecavir, Hepatitis B, Date of authorisation: 18/09/2017, Revision: 1, Status: Authorised

Case Medical Research ◽

10.31525/cmr-1177174 ◽

2019 ◽

Author(s):

Keyword(s):

Hepatitis B ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Viread, tenofovir disoproxil, Hepatitis B, Chronic,HIV Infections, Date of authorisation: 04/02/2002, Revision: 51, Status: Authorised

Case Medical Research ◽

10.31525/cmr-39964c ◽

2019 ◽

Author(s):

Keyword(s):

Hepatitis B ◽

Hiv Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Vosevi, sofosbuvir / velpatasvir / voxilaprevi, Hepatitis C, Chronic, Date of authorisation: 26/07/2017, Revision: 4, Status: Authorised

Case Medical Research ◽

10.31525/cmr-c4dbb9 ◽

2019 ◽

Author(s):

Keyword(s):

Hepatitis C ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text